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Abstract: Myasthenia gravis is one of the neurological diseases with a relatively recent 
history, full of mistakes, in which the British and German neurology schools have 
attempted to find answers when confronted with the unknown. The paper aims at 
making a historical account of the disease from its discovery in the 16th century, when 
the first case of myasthenia gravis was medically diagnosed, to the beginning of the 20th 
century, when the dawn of modern therapy started to show.  
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Disease is very old. Nothing about it has changed. It is only we who change as we learn to 
perceive what was formerly imperceptible. 
Jean Martin Charcot (1825-1893) 
 
Introduction 
Myasthenia gravis (MG) is a 
neuromuscular disease that may be congenital 
or not, immune-mediated or not, due to a 
presynaptic, synaptic or postsynaptic defect. 
The very etymology of the words myasthenia 
gravis reflect its definition, as it consists of the 
Greek words mios (gr.) meaning muscle, 
asthenia (gr.) meaning weakness and gravis 
(lat.) meaning severe.  
MG history is relatively recent, full or 
errors and ambiguities, a history in which 
especially the German and British neurology 
schools have attempted, over time, to find 
answers when confronted with the unknown. 
Writing is an art and good writings are 
expression of maturity (14), and various 
neurologists, psychiatrists, neurosurgeons, 
anatomists, pathologists and philosophers 
have tried to write its history throughout the 
centuries.  
Initially called Erb’s palsy, a term coined 
after the name of the German neurologist 
Wilhelm Erb (1840-1921) who achieved the 
first classical description of the illness, 
myasthenia gravis was included in the list of 
diseases under the name of the Erb-Goldflam 
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syndrome until 1895, when, at a medical 
conference in Berlin, the German neurologist 
and psychiatrist Friedrich Jolly (1844-1904), 
showed to the audience two patients suffering 
from this disease, which he called myasthenia 
gravis pseudoparalytica (1, 12). The first case 
of MG mentioned in the history of medicine 
may be considered the case of an Indian tribe 
chief, the Native-American Opechankanough 
(1554-1644) who, according to the historical 
records based on colonial correspondence, 
suffered from extreme muscle fatigue which 
made it impossible for him to walk and which 
was alleviated by rest. Moreover, the historical 
records also described the fact that 
Opechankanough suffered from bilateral 
palpebral ptosis, so that his eyelids were kept 
open by his servants (19). 
Thomas Willis (1621-1975) – the first 
description 
Many researchers (1, 2, 12, 20) credit the 
famous English neurologist Thomas Willis 
(1621-1675) (figure 1) with the first 
description of the MG disease. He is especially 
known in neurology and neurosurgery for 
Willis polygon, which he named circulus 
arteriosus cerebri and which he described very 
well in 1664, thus revolutionizing cerebral 
circulation physiology (7- 9, 17). 
In 1672, Professor Willis notes in several of 
his patients the occurrence of a chronic 
condition characterized by muscle fatigue, 
with fluctuating progress, yet typically 
aggravated by physical effort and alleviated by 
rest. It is much later that his descriptions were 
connected with MG, namely in 1903, by the 
English pediatrist Leonard George Guthrie 
(1858-1918), who writes down his 
assumptions in the paper entitled Myasthenia 
Gravis in the Seventeenth Century published 
by the prestigious Lancet Journal (11). 
In one of his books written in Latin, De 
anima Brutorum, and then translated into 
English in 1688 by the English poet Samuel 
Pordage (1633-1691), Thomas Willis describes 
as spurious palsy the case of a woman 
exhibiting fluctuating muscle fatigue in the 
limbs and tongue (28).  
When he looks for an explanation for these 
bizarre manifestations, Willis suggests the 
existence of a substance in the blood that 
would facilitate muscle contraction, and this 
type of palsy would be due to fluctuations in 
the blood concentration of this substance: it 
may be suspected, that not only de Spirits 
themselves,...are in fault but...the impotency of 
local motion doth in some measure also 
depend upon the fault of the explosive Copula, 
suffused everywhere from the blood, into the 
moving fibers (28). This assumption, too 
daring for the 17th century, cannot be 
recorded without the slightest shadow of a 
doubt, since Pordage’s work could not be a 
very faithful translation of Willis’ thoughts 
(13). Therefore, there are scientists who 
challenged the accuracy of Pordage’s 
description. 
Sir Samuel Wilks (1824-1911) – the grand 
old man of British medicine  
Two centuries had to elapse until the first 
modern description of MG was done by 
another English doctor, Sir Samuel Wilks 
(1824-1911) (figure 1) rightfully called the 
grand old man of British medicine (24). Of the 
four brilliant minds of the Guy’s Hospital in 
London, namely Richard Bright, Thomas 
  
 
 
 
Romanian Neurosurgery (2016) XXX 1: 77 - 82         79 
 
 
 
 
 
 
 
Addison, Thomas Hodgkin and Samuel Wilks, 
only the last acknowledged the importance of 
pathological anatomy and promoted it in 
numerous works published in the Guy’s 
Hospital Reports, which he edited between 
1854 and 1865. In all his publications, Wilks 
supported the performance of autopsy on 
every occasion in order to set correlations 
between clinical medicine and pathological 
anatomy. Samuel Wilks’ contributions 
changed medical thought both as concerns 
systemic diseases (lymphoma, intestinal 
inflammatory diseases, bacterial endocarditis, 
syphilis), and as regards neurological diseases 
(alcoholic neuropathy, epilepsy, migraine) 
(22). Moreover, Wilks was also the first scholar 
who claimed that in epilepsy, the seat of the 
condition was not in the spinal cord, but in the 
cerebral cortex (4, 18, 22, 23). 
In 1877 Wilks described the case of a 
woman of uncertain age suffering from bulbar 
palsy, whose disease progressed in a fluctuant 
manner from the viewpoint of symptom 
strength and who eventually died. After an 
autopsy had been conducted, although he was 
familiar with the histopathological changes 
occurring in the brainstem nuclei in case of 
bulbar palsy and motor neuron disease, 
Samuel Wilks noted the absence of 
macroscopic and microscopic changes. At 
first, he tried to account for the specificity of 
his case by diagnosing hysteria, but his 
conclusions were: bulbar paralysis; fatal; no 
disease found (27). 
Wilhelm Erb (1840-1921) – the first classical 
description of the disease 
The first classical description of MG may 
be found in the first book dealing exclusively 
with this disease and it was made in 1878, by 
the German neurologist Wilhelm Erb (1840-
1921) (figure 1). Thus, in his work entitled On 
a New Symptomatic Complex, Probably 
Bulbar, Erb described three cases with similar 
symptoms and concluded that diplopia, 
bilateral palpebral ptosis, dysphagia, facial 
palsy, neck muscle fatigue, all of them with 
fluctuating progress and numerous 
recurrences and relapses, were components of 
a new pathological entity, different from 
progressive bulbar palsy (6). Erb was also the 
first scholar who attempted to treat the 
condition by applying galvanic current and by 
administering iron, potassium iodide or 
quinine. The condition of one of the three 
cases improved after galvanotherapy, the 
condition of the second patient worsened and 
that of the third patient improved after 
quinine had been administered (20). 
After 1878 many cases of MG were 
described in medical literature as particular 
forms of bulbar palsy, with fatal fluctuating 
progress. The doctors noted that all these 
conditions had in common the fact that the 
forensic examination revealed no pathological 
findings. Among these cases, the German 
doctor Eisenlohr published in 1886 the case of 
an 18-year-old boy who had died due to 
respiratory muscle paralysis (5), the German 
neurologist Herman Oppenheim (1858-1919) 
published the case of a 29-year-old woman in 
1887 (21), while the English pathologist Julius 
Dreschfeld (1845-1907) published, in 1893, the 
case of a 36-year-old woman, which was very 
well documented from a pathological anatomy 
point of view (3). 
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Herman Hoppe (1867-1929) –elucidation of 
the characteristics of the disease 
Starting with 1892 doctors from countries 
other than Germany and England began to 
document such cases. The first one to do that 
was doctor Herman Hoppe (1867-1929), of the 
United States, who published a complex work 
dealing with the cases described by Wilks, 
Eisenlohr and Oppenheim under the name of 
a single condition, despite their being distinct 
from a clinical, paraclinical and 
histopathological point of view. He 
emphasizes the characteristics of the disease: 
target muscle groups, no muscle atrophy, 
circadian fatigability variations (more 
prominent in the evening) and progress which 
included remissions and relapses. He also 
noted that the muscular response to electric 
stimulation did not have the typical 
denervation appearance, and the 
histopathological examination surprisingly 
revealed no neural mass loss (16). 
Samuel Goldflam (1852-1932) – distinction 
from progressive bulbar palsy  
A year later, i.e. in 1893, the polish 
neurologist Samuel Goldflam (1852-1932) 
(figure 1) revived Erb’s theory and pointed out 
that muscle fatigue was the cardinal symptom 
and commented on the disease variants and 
severity, and suggests the idea of prognostic. In 
a review of Wilks’, Erb’s, Eisenlohr’s, 
Oppenheim’s and Hoppe’s works, he reports 
three new cases and describes the disease as an 
apparently curable bulbar paralytic symptom 
complex (10). This description is considered 
by many scholars “in many ways the most 
important ever written in the history of the 
disease” (25). Just like Erb before him, 
Goldflam groups the symptoms in a 
pathological entity which he clearly 
distinguishes from progressive bulbar palsy 
and hysteria, without however giving it a 
name. 
Friedrich Jolly (1844-1904) – myasthenia 
gravis pseudoparalytica 
In 1895, the German neurologist and 
psychiatrist Friedrich Jolly (1844-1904) (figure 
1) calls this condition for the first time 
myasthenia gravis pseudoparalytica when he 
reports the cases of two 14 and 15-year-old 
boys. By using faradic current for the electric 
stimulation of different groups of muscles, 
Jolly sets the electrophysiological pattern of 
MG. The test was known by the name of the 
Jolly test, yet the doctor’s residents would call 
it the not-so-jolly test because of the pain it 
inflicted. 
Jolly thus noted that fatigue also occurred 
in non-stimulated muscle groups, which 
virtually reiterated what Thomas Willis had 
suggested almost 250 years before, namely that 
MG physiopathology was due to a circulating 
factor causing muscle fatigue. Moreover, Jolly 
noticed that fatigability set in on indirect 
recurrent stimulation, through the nerve, and 
that muscle contraction stopped at some 
point. He concluded that MG seemed to be a 
neuromuscular plate condition (15). 
Starting with the 20th century, the number 
of MG cases increases exponentially, and the 
following natural step in the medical world 
was the attempt to clarify disease 
etiopathogenesis in order to find efficient 
therapies. 
The first connection between thymus and 
MG was suggested in 1899 by the German 
doctor Hermann Oppenheim (1858-1919) 
who discovered incidentally, when performing 
an autopsy on a MG patient, a tumor the size 
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of a tangerine (20). A few years later, i.e. in 
1901, the German forensic doctor Karl 
Weigert (1845-1904) detected a tumor in the 
anterior mediastinum of a MG patient, which 
originated in the thymus. The 5-5-3 cm tumor 
was made of lymphocytes, the same cells that 
also occurred in the striated muscle fibers. 
Weigert closed the case by concluding that it 
was a particular form of MG, complicated by a 
thymus lymphoma, which caused metastases 
in the deltoid and diaphragm muscles (26). 
Conclusions 
MG has a complicated history, with a 
golden age in the absence of which scientists 
would have been unable to elucidate the 
condition and doctors would have been unable 
to treat it. Although the beginnings were 
vague, with a description recorded by 
historians, as science and hence the man’s 
ability to understand things evolved, 
increasingly relevant proof was collected, 
which contributed to the current clearly 
outlined etiopathogenesis of MG and accurate 
therapeutic guidelines. The complexity of the 
disease still holds nowadays, as the medical 
world has been exploring it and placing an 
emphasis on the genes involved, on new 
autoantigens and on new therapies to be 
administered both during seizures and as 
background therapy. What lasted for almost 
350 years may be summarized in a single 
sentence: the first description originated in 
England, as did the first modern description of 
it, then its symptoms and name were set in 
Germany, whereas its therapy and 
immunopathological foundations were laid 
later, starting with 1930, in the United States. 
 
 
Figure 1 - Contributors to the physiopathology of the myasthenia gravis disease 
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